The new Dementia Trials Accelerator is set to receive £20m of government funding
Category: News
Approximately 8.2 million people were diagnosed with the infectious disease in 2023
danicopan shown to improve haemoglobin levels and reduce anaemia
New treatment option for patients with newly diagnosed multiple myeloma
CAL101 shows promising results and is set to enter phase 2 development
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
The five new programmes are designed to fit alongside full-time work and clinical practice
The two-year programme will use virtual reality technology to teach essential skills
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma